ERBB2 and breast carcinoma: Expression of LPP-mLIM1 and LPP-ΔABD severely impaired the ability of breast cancer cells to extravasate, when compared to NMuMG-ErbB2 cells expressing wild-type LPP (LPP-WT) (Fig. 5d).